Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biotechnology Index NYSE ETF (NY: FBT ) 171.99 -0.22 (-0.13%) Streaming Delayed Price Updated: 9:44 AM EDT, Oct 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Biotechnology Index NYSE ETF Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention April 13, 2023 U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of... Via Benzinga Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules April 13, 2023 A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug. Via Benzinga New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications April 12, 2023 New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this... Via Benzinga Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead April 11, 2023 In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating... Via Benzinga FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits April 06, 2023 Via Benzinga US Judge Weighs Nationwide Ban On Abortion Pills March 16, 2023 U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regulatory approval of the abortion pill mifepristone was proper. The judge is... Via Benzinga FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' March 01, 2023 Via Benzinga Lots Of & Increasing Evidence That Stocks Are Bottoming For Now May 23, 2022 On Friday we saw one of the more violent trading days. Stocks jumped at the open, sold off sharply to new lows, and then rocketed back in the last hour to close basically unchanged. Via Talk Markets How do Biotechnology Funds and ETFs Perform Over Five Years? March 21, 2022 Biotech investing can be difficult for short-term traders but can offer good returns over five years if balanced with other healthcare positions like the XLV. Via Talk Markets Biotech ETFs That Outperformed Last Week December 20, 2021 Though the broad U.S. market saw a tumultuous ride last week with most of the sectors in red, biotechnology was the biggest gainer. Via Talk Markets Biotech ETFs To Benefit From Latest Booster Update August 21, 2021 Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from... Via Talk Markets Exposures COVID-19 Q2 Growth 'Nothing Short Of Virtuous': Economist July 29, 2021 The coronavirus pandemic that began in 2020 and is persisting today has led many investors to hold poor market expectations. But maybe they shouldn’t be so pessimistic. What... Via Benzinga Exposures COVID-19 Top-Performing Biotech ETFs of Last Week June 14, 2021 Investors may want to tap the bullishness in the biotech sector with the best biotech ETFs of last week. Via Talk Markets 5 Top ETFs With Exposure To Biogen June 07, 2021 Here is a look at five ETFs with large exposure to Biogen shares. Via Talk Markets 5 Top ETFs With Exposure To Biogen June 07, 2021 For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that... Via Benzinga Exposures Product Safety Medical Miracles Inside Biotech ETFs May 24, 2021 The events of the past year focused a lot of attention on game changing developments made possible by the global biotech industry. Of the major names Moderna is the one where the original research and... Via Talk Markets Topics Intellectual Property Exposures COVID-19 Intellectual Property Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines May 08, 2021 The Biden administration announced support for the waiver of intellectual property protections for COVID-19 vaccines proposed by South Africa and India. Let’s take a look at ETFs that can suffer from... Via Talk Markets Topics Intellectual Property Exposures COVID-19 Intellectual Property Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
